Inactivated Polio And Rabies Vaccines Market, by Vaccine ( Inactivated Polio Vaccines and Inactivated Rabies Vaccines), By Method of Inactivation (Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation, and Others), By Age Group (Pediatrics and Adults), by Distribution Channel (Government and Private) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Jun 2023

Code : CMI3581

Pages :179

Formats :

Excel and PDF

Industry : Biotechnology

Market Challenges And Opportunities

Global Inactivated Polio And Rabies Vaccines Market – Driver

Increasing incidences of rabies in the population Increasing incidences of rabies in the population is expected to spur the global inactivated polio and rabies vaccines market growth over the forecast period. Despite the availability of vaccines for over 100 years, dog rabies has been found to be common in all regions with inadequate public health resources and limited access to preventive treatment. North America also have few diagnostic facilities for life-threatening diseases and surveillance of rabies occurrence among the animals is almost zero. For instance, in September 2021, Gavi is an international organisation, the Vaccine Alliance included human rabies vaccines, which would support scaling up rabies Postexposure prophylaxis (PEP) in Gavi-eligible countries. Gavi reported the rabies was checked and found in dog, bat, raccoon, and fox were found to be the carriers of rabies and rabies causes around 59,000 deaths world-wide every year.

Increasing awareness about polio among the population Increasing awareness about polio among the population is expected to drive the global inactivated polio and rabies vaccines market growth over the forecast period. For instance, According to WHO, 2021, world-wide incidences of polio have been decreased by 99%, since 1988 and only 20 cases of children suffering from polio were found in 2020. it has also been estimated that failure to eradicate polio, over the span of ten years, can result in 200,000 polio patients globally. Furthermore, active participation of government for increasing awareness among the population through social media platforms, newspapers, and announcements is expected to reduce number of polio cases world-wide.

Global Inactivated Polio And Rabies Vaccines Market - Restrains

Unavailability of the vaccines Unavailability of the vaccines is expected to hinder the growth of the market. Due to COVID-19 pandemic the supply chain is disrupted and manufactures are facing challenges, many countries are facing a shortage of vaccines. This has led to a delay in the distribution of vaccines, which in turn has hindered the growth of the market. Despite these challenges, the market is expected to recover once the vaccine supply chain is stabilized. Private Companies are increasing the production of vaccines & Governments are taking initiative to provide the vaccines.